The Jak-STAT pathway in rheumatoid arthritis

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1650-1653

  Walker, Jennifer G ^a   Smith, Malcolm D ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; JANUS KINASE; PROTEIN TYROSINE KINASE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

APOPTOSIS; CELL PROLIFERATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIMERIZATION; DISEASE ACTIVITY; EDITORIAL; FIBROBLAST; HEMATOPOIESIS; HUMAN; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24944520787     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Firestein G. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002;285:1-24.
3. Gadina M, Hilton D, Johnston JA, et al. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 2001;13:363-73.
4. Seidel HM, Lamb P, Rosen J. Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene 2000;19:2645-56.
5. Schindler CW. JAK-STAT signaling in human disease. J Clin Invest 2002;109:1133-7.
6. Ivashkiv LB, Hu X. Signaling by STATs. Arthritis Res 2004;6:159-68.
7. Chen W, Daines MO, Hershey GKK. Turning off signal transducer and activator of transcription (STAT): the negative regulation of STAT signaling. J Allergy Clin Immunol 2004;114:476-89.
8. Meeraz M, White J, Sheehan K, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996;84:431-42.
9. Yokota A, Narazaki M, Shima Y, et al. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells. J Rheumatol 2001;28:1952-9.
10. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, et al. Rheumatoid arthritis is a heterogeneous disease. Evidence for differences in the activation of the STAT-1 pathway between tissues. Arthritis Rheum 2003;48:2132-45.
11. Kasperkovitz P, Verbeet N, Smeets T, et al. Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 2004;63:233-9.
12. Hu X, Herrero C, Li W, et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 2002;3:859-66.
13. Krause A, Scaletta N, Ji J, Ivashkiv LB. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol 2002;169:6610-6.
14. de Hooge AS, van de Loo FA, Koenders MI, et al. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis. Arthritis Rheum 2004;50:2014-23.
15. Egan P, Lawlor K, Alexander W, Wicks I. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 2003;111:915-24.
16. Nishimoto N, Yoshizaki K, Miyasaka M, et al. Treatment of rheumatoid arthritis with humanised anti-interleukin-6 receptor antibody. Arthritis Rheum 2004;50:1761-9.
17. Levy DE, Lee C. What does Stat3 do? J Clin Invest 2002;109:1143-8.
18. Wang F, Sengupta TK, Zhong Z, Ivashkiv LB. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. J Exp Med 1995;182:1825-31.
19. Ernst M, Inglese M, Waring P, et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001;194:189-203.
20. Shouda T, Yoshida T, Hanada T, et al. Induction of the cytokine regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001;108:1781-8.
21. Frucht DM, Aringer M, Galon J, et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells and macrophages at sites of Th1-mediated inflammation. J Immunol 2000;164:4659-64.
22. Finnegan A, Grusby MJ, Kaplan CD, et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002;169:3345-52.
23. O'Shea JJ. Targeting the Jak/STAT pathway for immunosuppression. Ann Rheum Dis 2004;63 Suppl II:ii67-ii71.